Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: J Pediatr. 2015 Aug 5;167(4):834–839.e3. doi: 10.1016/j.jpeds.2015.06.067

Table 4.

Effect of Findings from the Most Severe Findings of Three Cranial Ultrasounds of Children Born at <32 weeks on Cerebral Palsy, and Mediation of the Association of MgSO4 with Cerebral Palsy

MgSO4 Placebo
Effect of Ultrasound Abnormality on the risk of CP (OR and 95% CI)* CP (n=40) No CP (n=737) CP (n=66) No CP (n=770) Effect of MgSO4 on the risk of CP after adjusting for CUS finding (OR and 95% CI)** % of the total effect explained by the CUS finding p-value for effect of CUS finding
Echodensity 9.6 (4.9, 19.1) 1 9 13 15 0.69 (0.45, 1.05) 20% 0.02
Echolucency 12.6 (7.4, 21.5) 7 19 22 24 0.69 (0.45, 1.05) 21% 0.04
PVL 34.9 (16.6, 73.4) 8 6 14 5 0.63 (0.40, 0.97) 3% 0.51
Ventriculomegaly 6.8 (4.0, 11.5) 6 33 18 27 0.62 (0.41, 0.95) 1% 0.54
IVH (all) 3.3 (2.2, 5.0) 15 145 32 149 0.63 (0.42, 0.96) 3% 0.54
 IVH grades III/IV 12.4 (6.4, 24.0) 2 13 16 11 0.66 (0.43, 1.00) 11% 0.10
Any of the above 5.2 (3.4, 7.8) 21 165 43 174 0.64 (0.42, 0.97) 8% 0.32

MgSO4 = magnesium sulfate; CP = cerebral palsy; PVL = periventricular leukomalacia; IVH = intraventricular hemorrhage; CUS = cranial ultrasound

*

Odds ratio (95% CI) adjusted for correlations between twins.

**

Odds ratio (95% CI) adjusted for correlations between twins. Note that without including the effect of the CUS finding, the odds ratio (95% CI) for CP of MgSO4 is 0.63 (0.42, 0.95)

Sobel test